Associate Professor at Nagoya City University, Midori Municipal Hospital, Japan
Hirotsugu Ohkubo is a distinguished researcher in respiratory medicine, specializing in interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), sarcopenia, and frailty. With a medical career spanning over two decades, he has held key positions at prominent institutions in Japan, including Tokyo Medical University and Nagoya City University. Ohkubo’s research has significantly advanced the understanding of IPF and related conditions, with his findings published in leading journals such as Journal of Allergy and Clinical Immunology and Internal Medicine. His work focuses on the pathogenesis of lung diseases, the use of CT imaging in diagnosis, and the impact of physical activity on respiratory health. Ohkubo’s contributions have been recognized with several awards, highlighting his commitment to improving patient care through research. His collaborative efforts and applied research have made a substantial impact on the field of respiratory medicine, both in Japan and internationally.
Profile
Education
Hirotsugu Ohkubo pursued his medical education at Tokyo Medical University, one of Japan’s leading institutions for medical research and education. He enrolled in the university’s Graduate School of Medicine, where he deepened his expertise in respiratory medicine, focusing on the complexities of interstitial lung diseases, sarcopenia, and frailty. During his graduate studies from April 2003 to December 2005, Ohkubo gained substantial clinical and research experience, which laid the foundation for his future contributions to the field. His time at Tokyo Medical University was marked by rigorous academic training, exposure to cutting-edge medical research, and the development of a strong foundation in pulmonary medicine. This education equipped him with the knowledge and skills necessary to excel in his clinical practice and research, ultimately leading to his recognition as a leading expert in the diagnosis and treatment of idiopathic pulmonary fibrosis and other complex respiratory conditions.
Professional Experience
Hirotsugu Ohkubo is an accomplished medical professional with extensive experience in respiratory medicine and interstitial lung diseases. He began his career with a residency at Shizuoka Saiseikai General Hospital, followed by a senior residency at Tokyo Medical University Graduate School. He then advanced to an Assistant Professor role at Tokyo Medical University, where he contributed to both clinical practice and research. Ohkubo further honed his expertise as Chief Physician at Nagoya Central Hospital before joining Nagoya City University Hospital as an Assistant Professor. His dedication and expertise led to his promotion to Lecturer, where he continued to impact the field through both teaching and research. Currently, Ohkubo serves as an Assistant Professor at Nagoya City University, Midori Municipal Hospital, where he remains actively involved in advancing the understanding and treatment of respiratory diseases, particularly idiopathic pulmonary fibrosis and sarcopenia. His professional journey reflects his commitment to improving patient outcomes and advancing medical research.
Hirotsugu Ohkubo’s research interests are deeply rooted in respiratory medicine, with a particular focus on interstitial lung diseases, including idiopathic pulmonary fibrosis (IPF). His work explores the complex pathogenesis of these conditions, aiming to improve diagnosis and treatment strategies. Ohkubo is also interested in the role of sarcopenia and frailty in respiratory diseases, examining how these conditions intersect with lung health. His research extends to the utilization of advanced imaging techniques, such as CT imaging, to enhance the understanding of lung disease progression. Additionally, Ohkubo investigates the molecular and cellular mechanisms underlying these diseases, seeking to develop more effective therapeutic interventions. Through his work, he aims to contribute to the betterment of clinical outcomes for patients suffering from chronic and debilitating respiratory conditions, with an overarching goal of advancing the field of respiratory medicine.
Research Skills
Hirotsugu Ohkubo possesses a comprehensive skill set that has driven his success in the field of respiratory medicine. His expertise includes advanced knowledge in diagnosing and treating interstitial lung diseases, particularly idiopathic pulmonary fibrosis. Ohkubo is adept at utilizing CT imaging to understand disease pathogenesis, which has been crucial in his research. His strong leadership skills are evident in his ability to guide research teams and collaborate effectively across institutions. He excels in general management, problem-solving, and time management, ensuring that his research projects are conducted efficiently and yield impactful results. Ohkubo’s excellent oral and written communication skills enable him to disseminate complex research findings to both scientific and clinical audiences. His ability to integrate clinical insights with research innovations underscores his proficiency in applied research, making significant contributions to respiratory health. These skills collectively highlight his capacity as a leading researcher in his field.
Awards and Recognition
Ohkubo’s contributions to the field have been recognized through several awards, including the Tokyo Medical University Thesis Encouragement Award (2009), the Award of Outstanding Reviewers for Internal Medicine (2015), and the Hisashi Okamoto Pulmonary Fibrosis Research Encouragement Award (2016). These accolades underscore his commitment to excellence in research and his impact on the field of respiratory medicine.
Conclusion
Hirotsugu Ohkubo is a highly accomplished researcher with a strong focus on respiratory medicine, particularly in the areas of idiopathic pulmonary fibrosis, sarcopenia, and interstitial lung diseases. His extensive research contributions, collaborative efforts, and applied research have had a significant impact on both national and international levels. While his work primarily centers on respiratory health, it also contributes to the broader understanding of environmental health and infectious diseases. His achievements and recognition in the field make him a suitable candidate for the Research for Best Researcher Award.
- Serum Periostin as a Biomarker for Comorbid Chronic Rhinosinusitis in Patients with Asthma
- Authors: T. Asano, Y. Kanemitsu, M. Takemura, M. Yokota, K. Fukumitsu, N. Takeda, et al.
- Journal: Annals of the American Thoracic Society
- Volume: 14 (5), 667-675
- Cited By: 77
- Year: 2017
- Normal Lung Quantification in Usual Interstitial Pneumonia Pattern: The Impact of Threshold-Based Volumetric CT Analysis for the Staging of Idiopathic Pulmonary Fibrosis
- Authors: H. Ohkubo, Y. Kanemitsu, T. Uemura, O. Takakuwa, M. Takemura, K. Maeno, et al.
- Journal: PLOS ONE
- Volume: 11 (3), e0152505
- Cited By: 68
- Year: 2016
- Tiotropium Attenuates Refractory Cough and Capsaicin Cough Reflex Sensitivity in Patients with Asthma
- Authors: K. Fukumitsu, Y. Kanemitsu, T. Asano, N. Takeda, H. Ichikawa, J.M.G. Yap, et al.
- Journal: The Journal of Allergy and Clinical Immunology: In Practice
- Volume: 6 (5), 1613-1620.e2
- Cited By: 54
- Year: 2018
- Early Decrease in Erector Spinae Muscle Area and Future Risk of Mortality in Idiopathic Pulmonary Fibrosis
- Authors: A. Nakano, H. Ohkubo, H. Taniguchi, Y. Kondoh, T. Matsuda, M. Yagi, et al.
- Journal: Scientific Reports
- Volume: 10 (1), 2312
- Cited By: 45
- Year: 2020
- Increased Capsaicin Sensitivity in Patients with Severe Asthma is Associated with Worse Clinical Outcome
- Authors: Y. Kanemitsu, K. Fukumitsu, R. Kurokawa, N. Takeda, M. Suzuki, J. Yap, et al.
- Journal: American Journal of Respiratory and Critical Care Medicine
- Volume: 201 (9), 1068-1077
- Cited By: 44
- Year: 2020
- Computer-Based Quantitative Computed Tomography Image Analysis in Idiopathic Pulmonary Fibrosis: A Mini Review
- Authors: H. Ohkubo, H. Nakagawa, A. Niimi
- Journal: Respiratory Investigation
- Volume: 56 (1), 5-13
- Cited By: 41
- Year: 2018
- Clinical Impact of Gastroesophageal Reflux Disease in Patients with Subacute/Chronic Cough
- Authors: Y. Kanemitsu, R. Kurokawa, N. Takeda, M. Takemura, K. Fukumitsu, T. Asano, et al.
- Journal: Allergology International
- Volume: 68 (4), 478-485
- Cited By: 40
- Year: 2019
- Diagnostic Utility of Fractional Exhaled Nitric Oxide in Prolonged and Chronic Cough According to Atopic Status
- Authors: T. Asano, M. Takemura, K. Fukumitsu, N. Takeda, H. Ichikawa, H. Hijikata, et al.
- Journal: Allergology International
- Volume: 66 (2), 344-350
- Cited By: 32
- Year: 2017
- Predictive Role of CYFRA21-1 and CEA for Subsequent Docetaxel in Non-Small Cell Lung Cancer Patients
- Authors: K. Sone, T. Oguri, K. Ito, Y. Kitamura, Y. Inoue, A. Takeuchi, S. Fukuda, et al.
- Journal: Anticancer Research
- Volume: 37 (9), 5125-5131
- Cited By: 31
- Year: 2017
- CYFRA 21-1 as a Predictive Marker for Non-Small Cell Lung Cancer Treated with Pemetrexed-Based Chemotherapy
- Authors: K. Sone, T. Oguri, M. Nakao, Y. Kagawa, R. Kurowaka, H. Furuta, S. Fukuda, et al.
- Journal: Anticancer Research
- Volume: 37 (2), 935-939
- Cited By: 30
- Year: 2017